Skip to content

An open clinical trial of a Siddha formulation Kandhaga rasayanam in ringworm infection.

evaluation of preclinical toxicity of a siddha formulation kandhaga rasayanam and its therapeutic efficacy in padarthamarai(dermatophytoses) by an open clinical trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2012/01/002362
Enrollment
50
Registered
2012-01-23
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B359- Dermatophytosis, unspecified Health Condition 2: L088- Other specified local infections of the skin and subcutaneous tissue Health Condition 3: null- tinea infection

Interventions

Intervention1: kandhaga rasayanam-2gram: internal drug containing sulphur,withania somnifera,smilax china etc. Dose: 2 grams B.D Duration: 48 days. frequency of visit: 7 days once. mode of administrat

Sponsors

national institute of siddha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients clinically diagnosed with tinea infection (tinea pedis, cruris, corporis, capitis, barbae, mannum ,ungium.). Patients of both sexes. Patients between 18 years to 60 years of age. Ability to understand and sign the informed consent. Direct microscopic examination of the skin scraping which shows positive for dermatophytes.

Exclusion criteria

Exclusion criteria: Pregnant women or nursing mother. Use of other topical or oral antifungal drugs, immunosuppressive drugs, anthelmintic drugs either currently or during the 2 weeks preceding initiation of drug trial. Allergy or hypersensitivity of any component of the drug. Clinical case of Eczema, Psoriasis, Lichen planus, Pityriasis versicolor, Drug induced eruptions, Urticaria, Intertrigo. Diabetic patients.

Design outcomes

Primary

MeasureTime frame
skin scrapping test negative for dermatophytesTimepoint: skin scrapping test negative for dermatophytes

Secondary

MeasureTime frame
relief from itching,burning sensation, ooze, vesicles, putules, hyperkeratosis etcTimepoint: 45 days

Countries

India

Contacts

Public ContactDrRSRamaswamy

NATIONAL INSTITUTE OF SIDDHA

meena_r83@yahoo.com9444088634

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 11, 2026